GlassScriptPhysician profile
Eric L Schwartzman
NPI 1558310268
$6,938.22
in general payments reported to CMS, 2019-2025
18 companies · $1,318 in 2025
The $1,318 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.13 · 2020: $313 · 2021: $246 · 2022: $564 · 2023: $3,001 · 2024: $1,461 · 2025: $1,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,213 · Food and Beverage: $2,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,212.97 |
| Food and Beverage | $2,566.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,061.82 | 2019-2025 | Aveir, Ensite, Assurity |
| Medtronic, INC. | $2,198.60 | 2023-2025 | Micra, Azure Xt Dr Mri Surescan, Capsurefix Novus Mri Surescan |
| Boston Scientific Corporation | $503.95 | 2023-2025 | Watchman Flx, Baylis Medical Company Radiofrequency Puncture Generator, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $231.44 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $120.15 | 2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $107.93 | 2021 | |
| Lantheus Medical Imaging, INC. | $105.68 | 2023-2024 | Definity |
| Pfizer INC. | $98.44 | 2020 | |
| Cardiva Medical, INC. | $96.61 | 2022-2024 | Ensoetm, Cardiva Vascade 6/7f Vcs |
| Cardiovascular Systems INC. | $83.20 | 2020-2022 | |
| Biotronik INC. | $76.17 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $69.04 | 2022 | |
| Abiomed | $55.39 | 2025 | |
| Shockwave Medical, INC | $38.24 | 2025 | |
| Terumo Medical Corporation | $32.30 | 2022-2025 | Glidewire |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $24.92 | 2024 | |
| Livanova USA, INC. | $22.08 | 2023 | Lifesparc |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.26 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Schwartzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.